Market Research Logo

Global Prader-Willi Syndrome Therapeutics Market 2018-2022

Global Prader-Willi Syndrome Therapeutics Market 2018-2022

About this market

The number of pipeline molecules in the global PWS therapeutics market is increasing at a good phase. The pipeline has many promising therapeutics agents, which are expected to boost the market growth. According to industry experts, approximately 15 therapeutics, are under different stages of development in the pipeline. The number of clinical trials is continuously increasing for the development of therapeutics for the treatment of PWS. This is expected to drive them market growth during our forecast period. These increasing number of special drug designations from regulatory bodies is expected to drive the market at a CAGR of close to 5% between 2018-2022.

Market Overview

Special drug designations

PWS is a rare disorder, and its prevalence rate is usually lower compared with other mainstream indications. Therefore, drug manufactures often hesitate to invest large amounts in drug discovery R&D. Therefore, regulatory bodies grant special drug designations, which will help in further development if the drug.

Lack of awareness of PWS

The sales of potential products are difficult to attain due to awareness issues. Though effective treatments available, individual attitudes, beliefs, poor treatment adherence and inadequate communication between clinicians and patients about PWS hinder the market growth.

For the detailed list of factors that will drive and challenge the growth of the Prader Willi syndrome therapeutics market during the 2018-2022, view our report.

Competitive Landscape

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. The vendors in the market forming strategic alliances by acquiring businesses gain competitive advantages. The market is formatting alliances between public and private stakeholders. The companies constantly focusing improving their market positions, the competitive environment among the players is quite intense


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global rare disease therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global – Market size and forecast 2017-2022 ($ mn)
      • Table Global – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase 2017-2018
    • Table Key clinical trial candidates for treatment of PWS
  • Market segmentation by product
    • Segmentation by product
      • Table Global PWS therapeutics market by product 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • Recombinant growth hormones – Market size and forecast 2017-2022
      • Table Recombinant growth hormones – Market size and forecast 2017-2022 ($ mn)
      • Table Recombinant growth hormones – Year-over-year growth 2018-2022 (%)
    • Others – Market size and forecast 2017-2022
      • Table Others – Market size and forecast 2017-2022 ($ mn)
      • Table Others – Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Strong pipeline
    • Increasing strategic alliances
    • Use of advanced technologies for diagnosis and treatment of PWS
  • Vendor landscape 2017
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Eli Lilly and Company
      • Table Eli Lilly and Company – Overview
      • Table Eli Lilly and Company – Business segments
      • Table Eli Lilly and Company – Organizational developments
      • Table Eli Lilly and Company – Geographic focus
      • Table Eli Lilly and Company – Segment focus
      • Table Eli Lilly and Company – Key offerings
      • Table Eli Lilly and Company – Key customers
    • Novartis
      • Table Novartis – Overview
      • Table Novartis – Business segments
      • Table Novartis – Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis – Segment focus
      • Table Novartis: Key offerings
      • Table Novartis – Key customers
    • Novo Nordisk
      • Table Novo Nordisk – Overview
      • Table Novo Nordisk – Business segments
      • Table Novo Nordisk – Organizational developments
      • Table Novo Nordisk – Geographic focus
      • Table Novo Nordisk – Segment focus
      • Table Novo Nordisk – Key offerings
      • Table Novo Nordisk – Key customers
    • Pfizer
      • Table Pfizer – Overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
      • Table Pfizer – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook